IT vendors go for the cold

Following the lead of freight carriers and logistics providers, IT vendors are targeting the growing need for cold storage and transport. In at least one case, vendors are delivering a one-two punch in the form of cold chain management coupled with track-and-trace systems for establishing drug pedigree.

Axway, among others, is working to capitalize on the data-gathering and transmitting capabilities of its solutions in the cold chain environment, reports Pharmaceutical Commerce. For vaccine and biologics manufacturers, end-to-end visibility may well be the holy grail of their regulatory affairs officers and supply chain managers. Aggregated data to provide such visibility would allow for making in-transit adjustments that could protect shipments.

In fact, temperature control and product flow visibility are two of the big three risk areas for healthcare supply chain managers, says a report in Industry Week. The third, of course, is fuel costs.

- see the Pharmaceutical Commerce article
- here's the Industry Week report

Suggested Articles

AbbVie will soon own Allergan’s prized Botox franchise, and along with its roughly $4 billion in sales, it will get a new $176 million plant.

Merck KGaA has big plans for a site in Switzerland where it intends to knit together biologics development and manufacturing. 

The FDA has found some issues with Biocon’s small molecule plant in Bengaluru, India.